Zobrazeno 1 - 10 of 15 pro vyhledávání: '"J L, Lichtenfeld"'
3
Combined Modality Therapy for Localized Hodgkin’s Disease
Autor: P H Wiernik, J L Lichtenfeld
Publikováno v: Oncology. 32:208-213
Some clinical trials have indicated that combination therapy with intensive radiation therapy followed by chemotherapy significantly prolongs the disease-free interval of patients with Hodgkin’s disea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4bd697b12912ea9a3ffa61bd62e6a448
https://doi.org/10.1159/000225070
Zobrazit plný text záznamu
5
Combined modality therapy for localized Hodgkin's disease. A seven-year update of an early study
Autor: P H, Wiernik, J L, Lichtenfeld
Publikováno v: Oncology. 32(5-6)
Some clinical trials have indicated that combination therapy with intensive radiation therapy followed by chemotherapy significantly prolongs the disease-free interval of patients with Hodgkin's disease confined to lymph nodes. The present report upd
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b8d51d47a1ff8d302b4620d37e1309a1
https://pubmed.ncbi.nlm.nih.gov/1228536
Zobrazit plný text záznamu
6
Lymph node calcification secondary to chemotherapy for histiocytic lymphoma
Autor: M E, Bohlman, J L, Lichtenfeld, S M, Goldman
Publikováno v: Diagnostic imaging. 50(5)
The fifth instance of lymph node calcification secondary to chemotherapy is reported 4 months after the onset of treatment. The recognition of the presence of such calcification is of significance because it is felt to indicate a favorable response t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::34b6f4b5fc4cc88f9cfbad02adb88b08
https://pubmed.ncbi.nlm.nih.gov/7028431
Zobrazit plný text záznamu
7
Phase I clinical and pharmacological study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide using an intermittent biweekly schedule
Autor: D A, Van Echo, D F, Chiuten, P E, Gormley, J L, Lichtenfeld, M, Scoltock, P H, Wiernik
Publikováno v: Cancer research. 39(10)
4'-(9-Acridinylamino)methanesulfon-m-anisidide (m-AMSA, NSC 249992), an acridine derivative, was given to 28 patients with solid tumors and one patient with Hodgkin's disease in a Phase I clinical trial. The dose schedule used was a single dose given
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7f70d214b63fad8cb6995c5b487c372e
https://pubmed.ncbi.nlm.nih.gov/476624
Zobrazit plný text záznamu
9
Antibody response in patients with acute nonlymphocytic leukemia
Autor: C A, Schiffer, J L, Lichtenfeld, P H, Wiernik, M R, Mardiney, J M, Joseph
Publikováno v: Cancer. 37(5)
Lymphocytotoxic (LCT) and anti-red blood cell (ABO) antibodies were measured serially in adult patients with acute nonlymphocytic leukemia (ANLL) receiving induction chemotherapy. The antigenic stimulus was provided by multiple platelet transfusions,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::cd9b7bb6d8faa9105eef0eb33674fe77
https://pubmed.ncbi.nlm.nih.gov/1260708
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje